Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-03 8:51 pm Purchase | 2024-12-31 | 13G | Universe Pharmaceuticals INC UPC | SABBY MANAGEMENT LLC | 727,190 9.900% | 727,190 (New Position) | Filing History |
| 2025-01-03 8:18 pm Purchase | 2024-12-31 | 13G | Volcon, Inc. VLCN | SABBY MANAGEMENT LLC | 56,034 9.900% | 56,034 (New Position) | Filing History |
| 2025-01-03 7:50 pm Purchase | 2024-12-31 | 13G | Applied DNA Sciences, Inc. APDN | SABBY MANAGEMENT LLC | 5,224,206 10.000% | 5,224,206 (New Position) | Filing History |
| 2025-01-03 7:25 pm Purchase | 2024-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | SABBY MANAGEMENT LLC | 69,555 9.900% | 69,555 (New Position) | Filing History |
| 2025-01-03 6:16 pm Sale | 2024-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT LLC | 29,051 4.900% | -191,612 (-86.83%) | Filing History |
| 2025-01-03 5:59 pm Purchase | 2024-12-31 | 13G | Cyngn Inc. CYN | SABBY MANAGEMENT LLC | 2,148,268 9.900% | 2,095,048 (+3936.54%) | Filing History |
| 2025-01-03 5:35 pm Sale | 2024-12-31 | 13G | Phunware, Inc. PHUN | SABBY MANAGEMENT LLC | 0 0.000% | -200,132 (Position Closed) | Filing History |
| 2025-01-03 5:19 pm Sale | 2024-12-31 | 13G | iBio, Inc. IBIO | SABBY MANAGEMENT LLC | 19,250 0.200% | -181,053 (-90.39%) | Filing History |
| 2025-01-03 4:35 pm Sale | 2024-12-31 | 13G | TransGlobe Energy Corporation TGA | SABBY MANAGEMENT LLC | 0 0.000% | -5,338,587 (Position Closed) | Filing History |
| 2025-01-03 4:17 pm Purchase | 2024-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 36,135 4.900% | 34,823 (+2653.29%) | Filing History |
| 2025-01-03 3:54 pm Sale | 2024-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | SABBY MANAGEMENT LLC | 60,325 4.900% | -12,152 (-16.77%) | Filing History |
| 2025-01-03 3:31 pm Purchase | 2024-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | SABBY MANAGEMENT LLC | 27,587 4.900% | 27,143 (+6116.33%) | Filing History |
| 2025-01-03 2:56 pm Purchase | 2024-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | SABBY MANAGEMENT LLC | 13,063 0.700% | 11,436 (+703.06%) | Filing History |
| 2025-01-03 2:12 pm Purchase | 2024-12-31 | 13G | Fangdd Network Group Ltd. DUO | SABBY MANAGEMENT LLC | 1,280,488 4.900% | 1,280,381 (+1199503.78%) | Filing History |
| 2025-01-03 1:38 pm Purchase | 2024-12-31 | 13G | GlucoTrack, Inc. GCTK | SABBY MANAGEMENT LLC | 32,353 4.900% | 11,481 (+55.01%) | Filing History |
| 2025-01-03 12:57 pm Sale | 2024-12-31 | 13G | Recon Technology, Ltd. RCON | SABBY MANAGEMENT LLC | 0 0.000% | -191,797 (Position Closed) | Filing History |
| 2025-01-03 12:41 pm Sale | 2024-12-31 | 13G | Arcadia Biosciences, Inc. RKDA | SABBY MANAGEMENT LLC | 68,111 4.900% | -29,194 (-30.00%) | Filing History |
| 2025-01-02 9:01 pm Sale | 2024-12-31 | 13G | Mobiquity Technologies, Inc. MOBQ | SABBY MANAGEMENT LLC | 0 0.000% | -144,867 (Position Closed) | Filing History |
| 2025-01-02 8:40 pm Purchase | 2024-12-31 | 13G | Revelation Biosciences, Inc. REVB | SABBY MANAGEMENT LLC | 26,062 4.900% | 25,222 (+3002.34%) | Filing History |
| 2025-01-02 7:13 pm Sale | 2024-12-31 | 13G | TUANCHE LTD ADR TCXXXX | SABBY MANAGEMENT LLC | 146,754 5.000% | -2,237,959 (-93.85%) | Filing History |